Proteolix
Latest round
- Series C
Last raised
- Sep 2008
Total raised
- $142M
Investors
- 7
About Proteolix
Proteolix is engaged in the discovery and development of novel therapeutics that target protein degradation pathways for cancer and autoimmune diseases.
Who invested in Proteolix
7 investors across 4 rounds
See all investors in Proteolix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Proteolix
Who invested in Proteolix?
Proteolix has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteolix raised?
Proteolix has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Proteolix last raise money?
Proteolix's most recent round on record is a Series C, in Sep 2008.
What does Proteolix do?
Proteolix is engaged in the discovery and development of novel therapeutics that target protein degradation pathways for cancer and autoimmune diseases.
Where is Proteolix headquartered?
Proteolix is headquartered in San Francisco, US.
Which VCs invest in companies like Proteolix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Proteolix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Proteolix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.